Conclusions: The results indicate a willingness on the part of most parents to treat a child at high risk for affective illness early in the course of symptom evolution, even prior to a full syndromic illness or diagnosis.
Multiple reports of pain over time allow integration of symptom evolution in the assessment of patients' pain severity.
It may also be that targeted interventions at high-risk populations aimed at symptom monitoring could be more effective at recognising symptom evolution (Smith et al, 2013).
In healthcare, data visualization has already been used in the areas of patient education, symptom evolution, patient cohort analysis, EHR data and design, and patient care plans.
Few data exist on natural history of irritable bowel syndrome (IBS) in children; therefore we investigated symptoms evolution over time in a cohort of children with IBS.
Stool passage was reported as easier for 40.9% of children at Week 4. No between-group differences in symptom score evolution were observed with respect to cramps, flatulence or anal irritation.
These infections are characterized by slow onset, middle-intensity symptoms, chronic evolution, and high tolerance to antibiotics and other antimicrobials [44].
After verifying the temporal consistency of such information in every subject, we proceeded to check the temporal consistency of such information with the generic clinical symptoms of evolution of avian influenza.
The insertion of the prosthetic medical devices for different exploratory or therapeutical purposes, especially in severe pathological conditions, represents a risk factor for the occurrence of chronic infections in developed countries, being characterized by slow onset, middle intensity symptoms, chronic evolution, and resistance to antibiotic treatment [2].
The insertion of prosthetic medical devices for different exploratory or therapeutical purposes, especially in severe pathological conditions, represents a risk factor for the occurrence of chronic infections in developed countries, being characterized by slow onset, middle-intensity symptoms, chronic evolution, and resistance to antibiotic treatment [22].
The biofilm associated infections are implicated in the etiology of 80% of human infections [ 8], being characterized by slow onset, middle intensity symptoms, chronic evolution, and resistance to antibiotic treatment [ 16], requiring complex multidrug treatment strategies [ 17].
